Zimmer Biomet Holdings Stock News

Zimmer Biomet (NYSE:ZBH) updated its FY 2021 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $7.320-$7.470 for the period, compared to the Thomson Reuters consensus estimate of $7.700. The company issued revenue guidance of $7.82 billion-$7.90 billion, compared to the consensus revenue estimate of $8.05 billion. A number of brokerages []

A prosthetic is an artificial part of the body, and when you are discussing a dental implant prosthetic, you are referring to two different parts, the metal insert that connects to the jawbone and the actual tooth itself. Worldwide Market Reports

The Spinal Trauma Devices market is a comprehensive market research report which provides market analysis with a historical & futuristic perspective for the following parameters; market size, revenue, demand, and supply data (as applicable). The report offers a detailed market

WARSAW, Ind., Nov. 18, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Chairman, President and CEO Bryan Hanson and Executive Vice President and CFO Suky Upadhyay will be presenting at Evercore ISI''s 4th

Market Intelligence Data has released a new report on the global Orthopedic Implant Material market. The document gives a complete evaluation of the market. It understands market development through in-depth insights, tracking historical results and analysing current scenarios and future

Chile Minimally Invasive surgical Instruments Market: Overview The Chile minimally invasive surgical instruments market is predicted to experience significant growth in the upcoming years. This market growth is on the back of various improvements in the healthcare infrastructure. Further, easy access

This Ortho and Osteobiologics market report provides an in-depth analysis of significant industry developments, competition overviews, company share analysis, and key players'' tactics, including advancements, acquisitions, and new product development, in order to maintain their market position. This global market

The Spinal Devices market is a comprehensive market research report which provides market analysis with a historical & futuristic perspective for the following parameters; market size, revenue, demand, and supply data (as applicable). The report offers a detailed market analysis

The "Brazil Dental Implants Market Analysis - COVID19 - 2021-2027 - MedSuite - Includes: Dental Implants, Final Abutments, Instrument Kits, Treatment Planning Software & Surgical Guides" report has been added to ResearchAndMarkets.com''s offering. Brazil dental implant and final abutment market was valued at $145 million in 2020. This is expected to increase over the forecast period at a CAGR of 13% to reach $341.7 million in 2027. Throughout this medical market research, the publisher analyzed 26 Dental Implants companies in Brazil and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts. Brazilian Dental Implants Market Insights An ongoing trend in the dental implant industry in a cost-sensitive environment like Brazil is the presence of off-label sales. These dental implants are labeled as generic and are imitation products that claim to be bioequivalent to premium implants, such as those offered by Zimmer Biomet.

Related Stocks: BIIB , IKNA , ABBV , GLPG , SIBN , LUNG , ADGI , ZBH , HCA , ERAS , SGEN , CTKB , AUPH , ASND , TRIL , ARCT , ALXN , ALEC ,

Related Stocks: ONB , ABT , ITOT , CRM , TTC , IEMG , SNOW , CRWD , GSLC , BYND , PSA , AGNC , IESC , NEA , XLG , ZBH , THC , SPAB ,

Parametric Portfolio Associates LLC raised its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 7.5% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 705,500 shares of the medical equipment providers stock after purchasing an additional 49,009 shares during the quarter. Parametric Portfolio []

WARSAW, Ind., Nov. 15, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the "Company") today announced the commencement of tender offers (collectively, the "Tender Offers" and each a "Tender Offer") to purchase for cash (i) any and all

Zimmer Biomet Holdings Inc's (NYSE: ZBH) Q3 sales decreased marginally by 0.3% Y/Y to $1.92 billion (down 0.8% on a constant currency basis), missing the Street estimate of $1.95 billion. Sales dip

Zimmer Biomet Holdings Inc. (ZBH) CEO Bryan Hanson on Q3 2021 Results - Earnings Call Transcript